Zhangzhou Pientzehuang Pharmaceutical Co Ltd banner

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 162.8 CNY -0.12% Market Closed
Market Cap: ¥98.2B

Wall Street
Price Targets

Price Targets Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Wall Street analysts forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 230.72 CNY with a low forecast of 146.45 CNY and a high forecast of 312.9 CNY.

Lowest
Price Target
146.45 CNY
10% Downside
Average
Price Target
230.72 CNY
42% Upside
Highest
Price Target
312.9 CNY
92% Upside
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors:
Price Targets
FIZZ
National Beverage Corp
-2% Downside

Revenue
Forecast

20% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
20% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

21% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
21% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

For the last 13 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 6%.

Net Income
Forecast

21% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
21% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price target?
Price Target
230.72 CNY

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 230.72 CNY with a low forecast of 146.45 CNY and a high forecast of 312.9 CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 5%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 6%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett